ストックスクリーナーアプリを入手
14.16
0.50%
0.07
アフターアワーズ：
14.16
前日終値:
$14.09
開ける：
$14.14
24時間の取引高:
964.96K
Relative Volume:
0.90
時価総額：
$11.79B
収益：
$3.85B
当期純損益:
$667.93M
株価収益率:
21.55
EPS:
0.657
ネットキャッシュフロー:
$142.30M
1週間 パフォーマンス:
-0.14%
1か月 パフォーマンス:
+1.22%
6か月 パフォーマンス:
-7.63%
1年 パフォーマンス:
-9.06%
1日の値動き範囲:
$14.08
$14.20
1週間の範囲:
$14.03
$14.32
52週間の値動き範囲:
$12.26
$16.17
Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile
RDY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RDY
Dr Reddys Laboratories Ltd Adr
|
14.16 | 11.73B | 3.85B | 667.93M | 142.30M | 0.657 |
|
ZTS
Zoetis Inc
|
126.23 | 55.30B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.65 | 49.22B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.13 | 44.97B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.89 | 36.41B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
507.16 | 22.16B | 3.08B | 1.24B | 1.07B | 25.61 |
Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-05 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-12-19 | ダウングレード | Nomura | Buy → Neutral |
| 2024-01-11 | ダウングレード | Jefferies | Buy → Underperform |
| 2023-08-29 | ダウングレード | HSBC Securities | Buy → Hold |
| 2023-05-18 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2023-03-17 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-01-30 | 開始されました | JP Morgan | Underweight |
| 2022-11-14 | ダウングレード | Credit Suisse | Neutral → Underperform |
| 2022-01-03 | 再開されました | BofA Securities | Neutral |
| 2021-07-27 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2021-02-02 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-09-18 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-09-18 | アップグレード | Investec | Sell → Hold |
| 2020-01-28 | ダウングレード | CLSA | Buy → Outperform |
| 2020-01-27 | ダウングレード | CLSA | Buy → Outperform |
| 2020-01-09 | アップグレード | Citigroup | Sell → Buy |
| 2019-11-04 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2019-09-04 | アップグレード | Credit Suisse | Underperform → Outperform |
| 2019-07-01 | アップグレード | Macquarie | Neutral → Outperform |
| 2019-06-20 | 開始されました | Deutsche Bank | Hold |
| 2019-06-11 | 開始されました | Barclays | Equal Weight |
| 2019-05-20 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2019-02-19 | アップグレード | CLSA | Outperform → Buy |
| 2019-01-17 | ダウングレード | Citigroup | Neutral → Sell |
| 2017-09-21 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2017-08-31 | アップグレード | CLSA | Underperform → Outperform |
| 2017-07-28 | ダウングレード | CLSA | Underperform → Sell |
| 2016-07-27 | ダウングレード | HSBC Securities | Hold → Reduce |
| 2016-07-27 | ダウングレード | Jefferies | Hold → Underperform |
| 2016-02-10 | アップグレード | Credit Agricole | Underperform → Buy |
| 2015-11-10 | ダウングレード | Citigroup | Buy → Neutral |
すべてを表示
Dr Reddys Laboratories Ltd Adr (RDY) 最新ニュース
What does Infosys ADR stock rally on the NYSE mean for Infosys shares on the NSE, BSE? - livemint.com
Infosys ADR stock jumps over 56% over strong volumes on US stock market today — Details here - livemint.com
Validea's Top Health Care Stocks Based On Peter Lynch12/15/2025 - Nasdaq
FDA Weighs Rapid Review For Eli Lilly Obesity Pill As Novo Nordisk Nears Launch - Benzinga
FDA Weighs Rapid Review For Eli Lilly Obesity Pill As Novo Nordisk Nears Launch - Sahm
Asian Equities Traded in the US as ADRs Fall in Thursday Trading - 富途牛牛
Asian ADRs Nudge Higher As Tech And Pets Take The Lead - Finimize
Arrowpoint Investment Partners Singapore Pte. Ltd. Acquires New Shares in Full Truck Alliance Co. Ltd. Sponsored ADR $YMM - Defense World
Asian ADRs Dip In The US As Volatility Continues - Finimize
Asian ADRs Kick Off The Week With Broad Gains - Finimize
Is Zoetis Stock Underperforming the Dow? - Barchart.com
US Stock Market today: Dow Jones, Nasdaq, S&P 500 open higher over improving Fed rate cut bets — Details here - livemint.com
Vise Technologies Inc. Makes New Investment in Dr. Reddy's Laboratories Ltd $RDY - MarketBeat
Apple Upgraded, DraftKings Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Migdal Insurance & Financial Holdings Ltd. Sells 20,000 Shares of Dr. Reddy's Laboratories Ltd $RDY - MarketBeat
Asia’s Biggest US-Listed Stocks Saw Mixed Results Today - Finimize
Fintech ADRs Dropped While Telecoms And Pharma Firmed Up - Finimize
Dr Reddy's ADR Slumps 10% After Bid To Launch Weight-Loss Drug In Canada Hits Regulatory Hurdle - MSN
L&T, Dr Reddys Labs, Coal India, Varun Beverages — Check Price Target Changes From Analysts - NDTV Profit
Why Dr Reddy’s stock may fall today; buzzing stocks list - BusinessLine
Indian pharma giant says Health Canada rejected its application to make generic semaglutide - The Globe and Mail
Asian ADRs See Mixed Results With Fintech In Focus - Finimize
Dr Reddys ADR Slumps 10% After Bid To Launch Weight-Loss Drug In Canada Hits Regulatory Hurdle - NDTV Profit
Dr Reddys Laboratories Ltd Adr (RDY) 財務データ
収益
当期純利益
現金流量
EPS
0.98%
13.98%
大文字化:
|
ボリューム (24 時間):